Studies from University of Occupational and Environmental Health Update Current Data on Rheumatoid Arthritis (Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in ...)

Source :: Obesity, Fitness & Wellness Week. July 6, 2019, 7524
Publication Year :: 2019
Abstract: 2019 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Autoimmune Diseases and Conditions - Rheumatoid Arthritis. [...]

Subjects :: Eli Lilly and Co. -- Product development
Incyte Corp. -- Product development
Physical fitness
Rheumatoid factor
Medical research
Pharmaceutical industry -- Product development
Arthritis -- Research -- Patient outcomes -- Care and treatment
Adalimumab -- Research -- Product development
Environmental health
Obesity
Autoimmune diseases
Editors
Health

Tools